Transfusion-associated graft-versus-host disease in a liver transplant recipient: An unusual presentation and review of the literature

Transfusion

Volumn 53, Issue 1, 2013, Pages 174-180

  O'Brien, Kerry L ^a   Pereira, Shalini E ^a   Wagner, Jeffrey ^a   Shadman, Mazyar ^a   Hendrie, Paul ^a   Nelson, Karen ^a   Gernsheimer, Terry B ^a   Price, Thomas ^a   Reyes, Jorge D ^a   Nester, Theresa ^a  

^a PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; APHERESIS; ARTICLE; BONE MARROW APLASIA; CASE REPORT; CD3+ T LYMPHOCYTE; CELL POPULATION; CHIMERA; ERYTHROCYTE; GRAFT RECIPIENT; HAPLOTYPE; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; TANDEM REPEAT; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE;

ERYTHROCYTE TRANSFUSION; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LIVER TRANSPLANTATION;

EID: 84872269419     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03686.x     Document Type: Article

References (28)

1. Triulzi D, Duquesnoy R, Nichols L, Clark K, Jukic D, Zeevi A, Meisner D,. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion 2006; 46: 885-8.
2. Rososhansky S, Badonnel M-CH, Hiestand LL, Popovsky MA, Szymanski IO,. Transfusion-associated graft-versus-host disease in an immunocompetent patient following cardiac surgery. Vox Sang 1999; 76: 59-63.
3. Kasai K, Nakamura Y, White R,. Amplification of a variable number of tandem repeats (VNTR) locus (cMCT118) by the polymerase chain reaction (PCR) and its application to forensic science. J Forensic Sci 1990; 35: 1196-200.
4. Schraml E, Daxberger H, Watzinger F, Lion T,. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Vienna experience. Leukemia 2003; 17: 224-7.
5. Chalandon Y, Vischer S, Helg C, Chapuis B, Roosnek E,. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience. Leukemia 2003; 17: 228-31.
6. Jeffreys AJ, Wilson V, Thein SL,. Individual-specific "fingerprints" of human DNA. Nature 1985; 316: 76-9.
7. Ruhl H, Bein G, Sachs UJH,. Transfusion-associated graft-versus-host disease. Transfus Med Rev 2009; 23: 62-71.
8. Utter GH, Lee TH, Rivers RM, Montalvo L, Wen L, Chafets DM, Reed WF, Busch MP,. Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion 2008; 48: 1609-15.
9. Patel KK, Patel AK, Ranjan RR, Shah AP,. Transfusion associated graft versus host disease following whole blood transfusion from an unrelated donor in an immunocompetent patient. Indian J Hematol Blood Transfus 2010; 26: 92-5.
10. Simon TL, Snyder EL, Solheim BG, Stowell CP, Strauss RG, Petrides M,. Rossi's principles of transfusion medicine. 4th ed. Bethesda (MD): American Association of Blood Banks; 2009.
11. Klein HG,. Transfusion-associated graft-versus-host disease: less fresh blood and more gray (Gy) for an aging population. Transfusion 2006; 46: 878-80.
12. US Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2010. 2011. [cited 2011 Sep 12]. Available from: URL: http://www.fda.gov/ biologicsbloodvaccines/safetyavailability/reportaproblem/ transfusiondonationfatalities/ucm254802.htm
13. Mack SJ, Tu B, Lazaro A, Yang R, Lancaster AK, Cao K, Ng J, Hurley CK,. HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population. Tissue Antigens 2008; 73: 17-32.
14. Anderson K,. Broadening the spectrum of patient groups at risk for transfusion-associated GVHD: implications for universal irradiation of cellular blood components. Transfusion 2003; 43: 1652-4.
15. Pavenski K, Kamel-Reid S, Wei C, Cserti-Gazdewich CM,. Lung transplantation complicated by graft-versus-host disease and confounded by incidental transfusion-associated macrochimerism. Transfusion 2008; 48: 2190-6.
16. Wisecarver JL, Cattral MS, Langnas AN, Shaw BW, Fox IJ, Heffron TG, Rubocki RJ,. Transfusion-induced graft-versus-host disease after liver transplantation. Transplantation 1994; 58: 269-71.
17. Roback JD, Combs MR, Grossman BJ, Hillyer CD,. Technical manual. 16th ed. Bethesda (MD): American Association of Blood Banks; 2008.
18. Triulzi DJ, Nalesnik MA,. Microchimerism, GVHD, and tolerance in solid organ transplantation. Transfusion 2001; 41: 419-26.
19. Tran AP, Edelman J,. Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout. Int J Rheum Dis 2011; 14: e33-e37.
20. Lukacs NW, Kunkel SL, Burdick MD, Lincoln PM, Strieter RM,. Interleukin-1 receptor antagonist blocks chemokine production in the mixed lymphocyte reaction. Blood 1993; 82: 3668-74.
21. Ness PM, Shoos Lipton K,. Selective transfusion protocols: errors and accidents waiting to happen. Transfusion 2001; 41: 713-5.
22. O'Brien KL, Champeaux AL, Sundell ZE, Short MW, Roth BJ,. Transfusion medicine knowledge in postgraduate year 1 residents. Transfusion 2010; 50: 1649-53.
23. King KE, Ness PM,. How do we prevent transfusion-associated graft-versus-host disease in children? Transfusion 2011; 51: 916-20.
24. Neves JF, Marques A, Valente R, Barata D,. Nonlethal, attenuated, transfusion-associated graft-versus-host disease in an immunocompromised child: case report and review of the literature. Transfusion 2010; 50: 2484-8.
25. Sebnem Kilic S, Kavurt S, Balaban Adim S,. Transfusion-associated graft-versus-host disease in severe combined immunodeficiency. J Investig Allergol Clin Immunol 2010; 20: 153-6.
26. Ohto H, Anderson KC,. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 1996; 10: 31-43.
27. Dwyre DM, Holland PV,. Transfusion-associated graft-versus-host disease. Vox Sang 2008; 95: 85-93.
28. Steiner ME, Assmann SF, Levy JH, Marshall J, Pulkrabek S, Sloan SR, Triulzi D, Stowell CP,. Addressing the question of the effect of RBC storage on clinical outcomes: the red cell storage duration study (RECESS). Transfus Apher Sci 2010; 43: 107-16.